Advertisement

Related Videos

Issues in Oncology

The ASCO Post Staff

Leonard B. Saltz, MD, on Interventional Pharmacoeconomics: A Pathway to Better Cancer Care

Leonard B. Saltz, MD, of Memorial Sloan Kettering Cancer Center, discusses interventional pharmacoeconomics as an important tool that can offer patients with cancer more efficacious and cost-effective care. Pharmacoeconomics may help reduce the high costs of cancer therapy, with evidence-based reductions in doses that maintain effective treatment.

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Opening Session Panel Discussion

Advertisement

Advertisement




Jan
27
Today In Oncology
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, Dies at 70
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Pembrolizumab Plus Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma
Cabozantinib and Temozolomide in Unresectable or Metastatic Leiomyosarcoma
Nutrition Muscle Loss Compromises Survival in Patients With Cervical Cancer Undergoing Chemoradiotherapy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo